Cargando…

Characterization of Rheumatoid Arthritis Subtypes Using Symptom Profiles, Clinical Chemistry and Metabolomics Measurements

OBJECTIVE: The aim is to characterize subgroups or phenotypes of rheumatoid arthritis (RA) patients using a systems biology approach. The discovery of subtypes of rheumatoid arthritis patients is an essential research area for the improvement of response to therapy and the development of personalize...

Descripción completa

Detalles Bibliográficos
Autores principales: van Wietmarschen, Herman A., Dai, Weidong, van der Kooij, Anita J., Reijmers, Theo H., Schroën, Yan, Wang, Mei, Xu, Zhiliang, Wang, Xinchang, Kong, Hongwei, Xu, Guowang, Hankemeier, Thomas, Meulman, Jacqueline J., van der Greef, Jan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3440441/
https://www.ncbi.nlm.nih.gov/pubmed/22984493
http://dx.doi.org/10.1371/journal.pone.0044331
_version_ 1782243163736375296
author van Wietmarschen, Herman A.
Dai, Weidong
van der Kooij, Anita J.
Reijmers, Theo H.
Schroën, Yan
Wang, Mei
Xu, Zhiliang
Wang, Xinchang
Kong, Hongwei
Xu, Guowang
Hankemeier, Thomas
Meulman, Jacqueline J.
van der Greef, Jan
author_facet van Wietmarschen, Herman A.
Dai, Weidong
van der Kooij, Anita J.
Reijmers, Theo H.
Schroën, Yan
Wang, Mei
Xu, Zhiliang
Wang, Xinchang
Kong, Hongwei
Xu, Guowang
Hankemeier, Thomas
Meulman, Jacqueline J.
van der Greef, Jan
author_sort van Wietmarschen, Herman A.
collection PubMed
description OBJECTIVE: The aim is to characterize subgroups or phenotypes of rheumatoid arthritis (RA) patients using a systems biology approach. The discovery of subtypes of rheumatoid arthritis patients is an essential research area for the improvement of response to therapy and the development of personalized medicine strategies. METHODS: In this study, 39 RA patients are phenotyped using clinical chemistry measurements, urine and plasma metabolomics analysis and symptom profiles. In addition, a Chinese medicine expert classified each RA patient as a Cold or Heat type according to Chinese medicine theory. Multivariate data analysis techniques are employed to detect and validate biochemical and symptom relationships with the classification. RESULTS: The questionnaire items ‘Red joints’, ‘Swollen joints’, ‘Warm joints’ suggest differences in the level of inflammation between the groups although c-reactive protein (CRP) and rheumatoid factor (RHF) levels were equal. Multivariate analysis of the urine metabolomics data revealed that the levels of 11 acylcarnitines were lower in the Cold RA than in the Heat RA patients, suggesting differences in muscle breakdown. Additionally, higher dehydroepiandrosterone sulfate (DHEAS) levels in Heat patients compared to Cold patients were found suggesting that the Cold RA group has a more suppressed hypothalamic-pituitary-adrenal (HPA) axis function. CONCLUSION: Significant and relevant biochemical differences are found between Cold and Heat RA patients. Differences in immune function, HPA axis involvement and muscle breakdown point towards opportunities to tailor disease management strategies to each of the subgroups RA patient.
format Online
Article
Text
id pubmed-3440441
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-34404412012-09-14 Characterization of Rheumatoid Arthritis Subtypes Using Symptom Profiles, Clinical Chemistry and Metabolomics Measurements van Wietmarschen, Herman A. Dai, Weidong van der Kooij, Anita J. Reijmers, Theo H. Schroën, Yan Wang, Mei Xu, Zhiliang Wang, Xinchang Kong, Hongwei Xu, Guowang Hankemeier, Thomas Meulman, Jacqueline J. van der Greef, Jan PLoS One Research Article OBJECTIVE: The aim is to characterize subgroups or phenotypes of rheumatoid arthritis (RA) patients using a systems biology approach. The discovery of subtypes of rheumatoid arthritis patients is an essential research area for the improvement of response to therapy and the development of personalized medicine strategies. METHODS: In this study, 39 RA patients are phenotyped using clinical chemistry measurements, urine and plasma metabolomics analysis and symptom profiles. In addition, a Chinese medicine expert classified each RA patient as a Cold or Heat type according to Chinese medicine theory. Multivariate data analysis techniques are employed to detect and validate biochemical and symptom relationships with the classification. RESULTS: The questionnaire items ‘Red joints’, ‘Swollen joints’, ‘Warm joints’ suggest differences in the level of inflammation between the groups although c-reactive protein (CRP) and rheumatoid factor (RHF) levels were equal. Multivariate analysis of the urine metabolomics data revealed that the levels of 11 acylcarnitines were lower in the Cold RA than in the Heat RA patients, suggesting differences in muscle breakdown. Additionally, higher dehydroepiandrosterone sulfate (DHEAS) levels in Heat patients compared to Cold patients were found suggesting that the Cold RA group has a more suppressed hypothalamic-pituitary-adrenal (HPA) axis function. CONCLUSION: Significant and relevant biochemical differences are found between Cold and Heat RA patients. Differences in immune function, HPA axis involvement and muscle breakdown point towards opportunities to tailor disease management strategies to each of the subgroups RA patient. Public Library of Science 2012-09-12 /pmc/articles/PMC3440441/ /pubmed/22984493 http://dx.doi.org/10.1371/journal.pone.0044331 Text en © 2012 van Wietmarschen et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
van Wietmarschen, Herman A.
Dai, Weidong
van der Kooij, Anita J.
Reijmers, Theo H.
Schroën, Yan
Wang, Mei
Xu, Zhiliang
Wang, Xinchang
Kong, Hongwei
Xu, Guowang
Hankemeier, Thomas
Meulman, Jacqueline J.
van der Greef, Jan
Characterization of Rheumatoid Arthritis Subtypes Using Symptom Profiles, Clinical Chemistry and Metabolomics Measurements
title Characterization of Rheumatoid Arthritis Subtypes Using Symptom Profiles, Clinical Chemistry and Metabolomics Measurements
title_full Characterization of Rheumatoid Arthritis Subtypes Using Symptom Profiles, Clinical Chemistry and Metabolomics Measurements
title_fullStr Characterization of Rheumatoid Arthritis Subtypes Using Symptom Profiles, Clinical Chemistry and Metabolomics Measurements
title_full_unstemmed Characterization of Rheumatoid Arthritis Subtypes Using Symptom Profiles, Clinical Chemistry and Metabolomics Measurements
title_short Characterization of Rheumatoid Arthritis Subtypes Using Symptom Profiles, Clinical Chemistry and Metabolomics Measurements
title_sort characterization of rheumatoid arthritis subtypes using symptom profiles, clinical chemistry and metabolomics measurements
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3440441/
https://www.ncbi.nlm.nih.gov/pubmed/22984493
http://dx.doi.org/10.1371/journal.pone.0044331
work_keys_str_mv AT vanwietmarschenhermana characterizationofrheumatoidarthritissubtypesusingsymptomprofilesclinicalchemistryandmetabolomicsmeasurements
AT daiweidong characterizationofrheumatoidarthritissubtypesusingsymptomprofilesclinicalchemistryandmetabolomicsmeasurements
AT vanderkooijanitaj characterizationofrheumatoidarthritissubtypesusingsymptomprofilesclinicalchemistryandmetabolomicsmeasurements
AT reijmerstheoh characterizationofrheumatoidarthritissubtypesusingsymptomprofilesclinicalchemistryandmetabolomicsmeasurements
AT schroenyan characterizationofrheumatoidarthritissubtypesusingsymptomprofilesclinicalchemistryandmetabolomicsmeasurements
AT wangmei characterizationofrheumatoidarthritissubtypesusingsymptomprofilesclinicalchemistryandmetabolomicsmeasurements
AT xuzhiliang characterizationofrheumatoidarthritissubtypesusingsymptomprofilesclinicalchemistryandmetabolomicsmeasurements
AT wangxinchang characterizationofrheumatoidarthritissubtypesusingsymptomprofilesclinicalchemistryandmetabolomicsmeasurements
AT konghongwei characterizationofrheumatoidarthritissubtypesusingsymptomprofilesclinicalchemistryandmetabolomicsmeasurements
AT xuguowang characterizationofrheumatoidarthritissubtypesusingsymptomprofilesclinicalchemistryandmetabolomicsmeasurements
AT hankemeierthomas characterizationofrheumatoidarthritissubtypesusingsymptomprofilesclinicalchemistryandmetabolomicsmeasurements
AT meulmanjacquelinej characterizationofrheumatoidarthritissubtypesusingsymptomprofilesclinicalchemistryandmetabolomicsmeasurements
AT vandergreefjan characterizationofrheumatoidarthritissubtypesusingsymptomprofilesclinicalchemistryandmetabolomicsmeasurements